NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 123 filers reported holding NUVATION BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,698,250 | -26.8% | 13,207,649 | -1.6% | 0.00% | 0.0% |
| Q2 2023 | $24,169,274 | +30.0% | 13,427,374 | +19.9% | 0.00% | 0.0% |
| Q1 2023 | $18,588,300 | -12.0% | 11,197,771 | +1.8% | 0.00% | 0.0% |
| Q4 2022 | $21,113,731 | -8.4% | 10,996,735 | +6.9% | 0.00% | 0.0% |
| Q3 2022 | $23,043,000 | -29.8% | 10,286,892 | +1.5% | 0.00% | 0.0% |
| Q2 2022 | $32,825,000 | -44.5% | 10,131,245 | -10.0% | 0.00% | -50.0% |
| Q1 2022 | $59,186,000 | -35.5% | 11,252,055 | +4.2% | 0.00% | 0.0% |
| Q4 2021 | $91,773,000 | +71.0% | 10,797,034 | +100.0% | 0.00% | 0.0% |
| Q3 2021 | $53,674,000 | +79.4% | 5,399,705 | +68.0% | 0.00% | +100.0% |
| Q2 2021 | $29,918,000 | +98.8% | 3,213,463 | +123.1% | 0.00% | – |
| Q1 2021 | $15,052,000 | – | 1,440,434 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 22,957,340 | $120,756,000 | 24.71% |
| Aisling Capital Management LP | 2,541,009 | $13,366,000 | 7.21% |
| EDBI Pte Ltd | 1,270,504 | $6,683,000 | 4.45% |
| Ally Bridge Group (NY) LLC | 1,137,152 | $5,981,000 | 4.43% |
| EcoR1 Capital, LLC | 13,896,543 | $73,096,000 | 2.29% |
| Boxer Capital, LLC | 4,341,009 | $22,834,000 | 1.17% |
| Baupost Group | 10,443,494 | $54,933,000 | 0.59% |
| Redmile Group, LLC | 3,471,709 | $18,261,000 | 0.57% |
| Avidity Partners Management LP | 4,855,006 | $25,537,000 | 0.53% |
| Abrams Capital Management | 3,811,513 | $20,049,000 | 0.47% |